Epigallocatechin gallate lowers triacylglycerols in non-obese type 2 diabetic rats by increasing adiponectin. - GreenMedInfo Summary

n/a

Abstract Title:

Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats.

Abstract Source:

Biosci Biotechnol Biochem. 2007 Aug ;71(8):2079-82. Epub 2007 Aug 7. PMID: 17690452

Abstract Author(s):

Masaya Shimada, Kazuki Mochizuki, Naoko Sakurai, Toshinao Goda

Article Affiliation:

Masaya Shimada

Abstract:

Epigallocatechin gallate (EGCG) reportedly enhances plasma adiponectin levels in models of insulin resistance and obesity. In this study, we found that EGCG increases plasma adiponectin levels and decreases plasma triacylglycerol levels in non-obese diabetic Goto-Kakizaki rats with insulin secretory dysfunction. These results suggest that EGCG ameliorates lipid metabolic abnormality even in non-obese rats, probably by increasing adiponectin production.

Article Published Date : Aug 01, 2007

Study Type : Animal Study

Additional Links

Substances : Catechin : CK(565) : AC(191)

Diseases : Adiponectin: Low Levels : CK(118) : AC(27), Diabetes Mellitus: Type 2 : CK(6029) : AC(1167), Triglycerides: Elevated : CK(846) : AC(142)

Pharmacological Actions : Adiponectin upregulation : CK(51) : AC(11)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version

Epigallocatechin gallate lowers triacylglycerols in non-obese type 2 diabetic rats by increasing adiponectin. - GreenMedInfo Summary

Print Options

Key Research Topics

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.